---
title: "Aspect Earns Metrigy's 2026 MetriStar Top Provider Award for Workforce Engagement Management Suites"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292081523.md"
description: "Aspect Software has been named the top provider in Metrigy's 2026 Workforce Engagement Management (WEM) Suites study, earning the MetriStar Top Provider Award. Leading its closest competitor by 29 points, Aspect's recognition is based on direct customer feedback and quantitative data demonstrating the tangible business impact of its offerings."
datetime: "2026-07-08T13:51:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292081523.md)
  - [en](https://longbridge.com/en/news/292081523.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292081523.md)
generator: "portal-rs"
---

# Aspect Earns Metrigy's 2026 MetriStar Top Provider Award for Workforce Engagement Management Suites

In Denver, Aspect Software has emerged as the leading provider in Metrigy's 2026 WEM Suites study on business success, standing out with a remarkable 29-point lead over the closest competitor. The company has been honored with the prestigious MetriStar Top Provider Award for Workforce Engagement Management (WEM) Suites. This recognition is a result of direct customer feedback and quantitative data analyzing the impact of a vendor's offerings on tangible business achievements. The thorough methodology employed in the analysis sets a high standard for evaluating providers in this industry.

## Related News & Research

- [IREN Just Passed Its Biggest AI Test as Microsoft and Nvidia Bet Billions](https://longbridge.com/en/news/296533962.md)
- [Oil set for second weekly rise as unsettled US-Iran war crimps supply](https://longbridge.com/en/news/296555193.md)
- [Google Is Reportedly Working with AMD for Its New TPU. What This Means for AMD Stock.](https://longbridge.com/en/news/296528134.md)
- [Trump Boosted INTC and DELL: Now He Says ‘Do Magnets’—Are MP and USAR Stocks Next?](https://longbridge.com/en/news/296591886.md)
- [Why Iovance Biotherapeutics Stock Hit 52-Week High](https://longbridge.com/en/news/296522969.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**